New York State Common Retirement Fund’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Buy |
+69,000
| New | +$102K | ﹤0.01% | 2627 |
|
|
2024
Q3 | – | Sell |
-555
| Closed | -$1K | – | 3304 |
|
|
2024
Q2 | $1K | Sell |
555
-45,100
| -99% | -$81.3K | ﹤0.01% | 3310 |
|
|
2024
Q1 | $58K | Buy |
45,655
+555
| +1% | +$705 | ﹤0.01% | 2938 |
|
|
2023
Q4 | $80K | Sell |
45,100
-700
| -2% | -$1.24K | ﹤0.01% | 2833 |
|
|
2023
Q3 | $76K | Buy |
45,800
+700
| +2% | +$1.16K | ﹤0.01% | 2858 |
|
|
2023
Q2 | $90K | Buy |
+45,100
| New | +$90K | ﹤0.01% | 2944 |
|